Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Experience sampling during antipsychotic dose reduction in psychotic disorder
NL-OMON48652Active, not recruiting
- Sponsor
- GGzE
- Start
- Mar 2019
- Countries
- 1
01
Overview
Open-label, single-arm trial in Schizophrenia Spectrum Disorders (SSD), sponsored by GGzE. Primary endpoints: Momentary psychotic experiences in daily life, Subjective well-being in daily life and 5 more. Started Mar 2019; status: active, not recruiting.
02
Conditions
Schizophrenia Spectrum Disorders (SSD)
Beyond the preview
Go deeper on NL-OMON48652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON48652.